A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer. (Q54350389)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 May 2014
edit
Language Label Description Also known as
English
A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.
scientific article published on 21 May 2014

    Statements

    A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit